This clinical overview details the latest evidence-based strategies for diagnosing and treating symptoms of benign prostatic hyperplasia in men.
The decision means Northern Ireland remains the only country in the UK where patients with this stage of prostate cancer are ...
In a statement, NICE said the new guidance for Talzenna will make it an option for around 2,400 people in England and reduce ...
Your urologist will use several tests to determine how severe your BPH is and whether it affects your bladder health. They may recommend watchful waiting if your BPH is mild. Watchful waiting means ...
Thousands of men with incurable prostate cancer will be offered a lifeline after an about-turn on NHS treatment.
Pharmaceutical Technology on MSN
NICE greenlights Pfizer’s Talzenna for NHS use
NICE now recommends NHS use of the daily pill to patients with metastatic prostate cancer.
Thousands of men in England living with advanced prostate cancer are poised to benefit from a new life-extending drug, ...
TORONTO, June 10, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (PROF) (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets ...
Benign prostatic hyperplasia (BPH) and overactive bladder (OAB) syndrome are distinct health conditions but may cause similar symptoms, such as urgent or frequent urination. BPH is the noncancerous ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results